US 11179367
Pharmaceutical compositions for treating cystic fibrosis
granted A61KA61K31/404A61K31/4045
Quick answer
US patent 11179367 (Pharmaceutical compositions for treating cystic fibrosis) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/404, A61K31/4045, A61K31/443, A61K31/4439